BioVenture VoiCes with Chris Garabedian Episode 32: ARCH Venture Partners' Bob Nelsen
20 snips
Jan 11, 2026 Bob Nelsen, co-founder of ARCH Venture Partners, shares his journey from Walla Walla to the heights of biotech investment. He discusses the vital role of risk-taking in American innovation and contrasts the adventurous spirit of tech with biotech's conservativism. Nelsen emphasizes AI's potential to revolutionize diagnostics and urges for regulatory reforms to speed up human trials. He also reveals ARCH's strategy of backing hungry founders over traditional pharma execs and highlights their commitment to impactful science over profit.
AI Snips
Chapters
Books
Transcript
Episode notes
Early Hustle And Curiosity
- Bob Nelsen sold gerbils at age seven and traded stocks at eleven, showing early entrepreneurial drive.
- He credits a permissive, curiosity-friendly upbringing and his nurse mother for encouraging risk-taking and work ethic.
Back Hunger Or Experience, Not Managers
- Back founders who are either deeply experienced or intensely hungry and surround inexperienced founders with an exec chair and supportive board.
- Avoid backing managers from big pharma as CEOs unless they show entrepreneurial grit.
Arch's Humble University Origins
- ARCH began by commercializing university inventions with volunteers and generous equity, exemplified by Everyday Learning.
- Steve Lazarus mentored early teams with wide rope and created incentives that paid off handsomely for young founders.
